Skip to main content
. Author manuscript; available in PMC: 2017 Mar 6.
Published in final edited form as: Ann Intern Med. 2016 May 31;165(5):325–333. doi: 10.7326/M16-0799

Appendix Table 2.

Sensitivity of economic outcomes to variation in key input parameters in a modeling analysis of 90-90-90 in South Africa.*

Basecase 5 yr 10 yr
Current Pace total cost $18,674 $38,353
UNAIDS Target total cost $26,639 $54,332

UNAIDS Target additional cost $7,965 $15,979

ICER ($/YLS) $2,720 $1,260

Testing/linkage efficiency (25%), Adherence/retention intervention cost (200%) 5 yr 10 yr

Current Pace total cost $18,674 $38,353
UNAIDS Target total cost $31,445 $64,370

UNAIDS Target additional cost $12,771 $26,016

ICER ($/YLS) $4,330 $2,040

Testing/linkage efficiency (90%), Adherence/retention intervention cost (50%) 5 yr 10 yr

Current Pace total cost $18,674 $38,353
UNAIDS Target total cost $24,343 $49,533

UNAIDS Target additional cost $5,668 $11,180

ICER ($/YLS) $1,940 $890

ART costs (50%) 5 yr 10 yr

Current Pace total cost $17,002 $34,579
UNAIDS Target total cost $23,784 $47,525

UNAIDS Target additional cost $6,782 $12,947

ICER ($/YLS) $2,270 $980

ART costs (50%), testing/linkage efficiency (90%), Adherence/retention intervention cost (50%) 5 yr 10 yr

Current Pace total cost $17,002 $34,579
UNAIDS Target total cost $21,487 $42,726

UNAIDS Target additional cost $4,485 $8,147

ICER ($/YLS) $1,490 $600

Abbreviations: ICER, incremental cost-effectiveness ratio; YLS, years of life saved

*

All costs are reported in 2014 USD. Total costs are reported undiscounted, in millions; ICERs are calculated as Δ$/ΔYLS of UNAIDS Target strategy compared to Current Pace strategy. Discounted values at 3% per year are used for incremental cost-effectiveness ratios.